Harmony Biosciences Holdings Stock News

Harmony Biosciences Holdings, Inc. (HRMY) CEO John Jacobs on Q4 2021 Results - Earnings Call Transcript

Harmony Biosciences Holdings, Inc. (HRMY) delivered earnings and revenue surprises of 96.88% and 3.15%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead

Harmony Biosciences press release (HRMY): Q4 Non-GAAP EPS of $0.63 beats by $0.12.Revenue of $91.21M (+62.0% Y/Y) beats by $1.68M.

WAKIX® (pitolisant) Net Revenue Increased 62% Year-over-Year to $91.2 Million for Fourth Quarter 2021 and 91% to $305.4 Million for Full Year

WAKIX ® (pitolisant) Net Revenue Increased 62% Year-over-Year to $91.2 Million for Fourth Quarter 2021 and 91% to $305.4 Million for Full Year

PLYMOUTH MEETING, Pa., Feb. 14, 2022 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that it will issue a…

PLYMOUTH MEETING, Pa., Feb. 14, 2022 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative the

Harmony Biosciences Holdings Inc (HRMY) shares closed today at 1.1% below its 52 week high of $44.39, giving the company a market cap of $2B. The stock is currently up 21.4% year-to-date, up 20.3% over the past 12 months, and up 18.6% over the past five years. This week, the Dow Jones Industrial Average rose 1.6%, and the S&P 500 rose 2.3%. Trading Activity Trading volume this week was 7.1% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -323.0% The company's stock price performance over the past 12 months beats the peer average by -272.4% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Harmony Biosciences Holdings Inc (HRMY) shares closed today at 1.1% below its 52 week high of $44.39, giving the company a market cap of $2B. The stock is currently up 21.4% year-to-date, up 20.3% over the past 12 months, and up 18.6% over the past five years. This week, the Dow Jones Industrial Average rose 1.6%, and the S&P 500 rose 2.3%. Trading Activity Trading volume this week was 5.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -323.0% The company's stock price performance over the past 12 months beats the peer average by -272.4% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Equities research analysts expect Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) to announce earnings per share of $0.34 for the current quarter, Zacks reports. Four analysts have made estimates for Harmony Biosciences’ earnings, with the highest EPS estimate coming in at $0.42 and the lowest estimate coming in at $0.27. Harmony Biosciences reported earnings per share of […]

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) was the recipient of a large increase in short interest in November. As of November 30th, there was short interest totalling 3,220,000 shares, an increase of 22.0% from the November 15th total of 2,640,000 shares. Currently, 12.9% of the companys stock are short sold. Based on an average daily volume []

Wall Street analysts expect that Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) will post $0.34 earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Four analysts have issued estimates for Harmony Biosciences’ earnings, with the lowest EPS estimate coming in at $0.27 and the highest estimate coming in at $0.42. Harmony Biosciences posted […]

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stock analysts at Jefferies Financial Group upped their FY2024 earnings per share (EPS) estimates for Harmony Biosciences in a research report issued on Wednesday, December 1st. Jefferies Financial Group analyst C. Howerton now forecasts that the company will earn $6.79 per share for the year, up from their previous [] The post Jefferies Financial Group Weighs in on Harmony Biosciences Holdings, Inc.s FY2024 Earnings (NASDAQ:HRMY) appeared first on ETF Daily News .

Oppenheimer initiated coverage on shares of Harmony Biosciences (NASDAQ:HRMY) in a report published on Tuesday, Analyst Price Targets reports. The firm issued an outperform rating and a $55.00 price objective on the stock. Oppenheimer also issued estimates for Harmony Biosciences Q4 2021 earnings at $0.36 EPS, FY2021 earnings at $0.56 EPS, Q1 2022 earnings at []